FTM
First Turn Management Portfolio holdings
AUM
$536M
This Quarter Return
-0.83%
1 Year Return
+36.36%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$558M
AUM Growth
+$558M
(-12%)
Cap. Flow
-$41.8M
Cap. Flow
% of AUM
-7.48%
Top 10 Holdings %
Top 10 Hldgs %
44.81%
Holding
45
New
7
Increased
11
Reduced
13
Closed
9
Top Buys
| 1 |
Janux Therapeutics
JANX
|
$20.5M |
| 2 |
Revolution Medicines
RVMD
|
$17.7M |
| 3 |
Exact Sciences
EXAS
|
$17.4M |
| 4 |
Xenon Pharmaceuticals
XENE
|
$14.1M |
| 5 |
HealthEquity
HQY
|
$12.1M |
Top Sells
| 1 |
Transmedics
TMDX
|
$17.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$16.4M |
| 3 |
Establishment Labs
ESTA
|
$15.4M |
| 4 |
Repligen
RGEN
|
$13.2M |
| 5 |
Krystal Biotech
KRYS
|
$12.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Oric Pharmaceuticals
ORIC
$994M
| $11.7M | 2.1% |
1,451,037
| – | – |
|
27
Arcellx
ACLX
$3.85B
| $11.7M | 2.09% |
152,356
-61,942
| -29% | -$4.75M |
|
28
Apogee Therapeutics
APGE
$2.17B
| $11.4M | 2.05% |
+252,725
| New | +$11.4M |
|
29
Harrow
HROW
$1.44B
| $10.2M | 1.83% |
304,874
-21,708
| -7% | -$728K |
|
30
Biohaven
BHVN
$1.63B
| $9.8M | 1.76% |
262,442
-53,374
| -17% | -$1.99M |
|
31
CorMedix
CRMD
$1.11B
| $8.27M | 1.48% |
+1,021,421
| New | +$8.27M |
|
32
ARS Pharmaceuticals
SPRY
$1.15B
| $6.26M | 1.12% |
593,291
| – | – |
|
|
BCAX
33
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
| $6.03M | 1.08% |
346,170
-216,221
| -38% | -$3.77M |
|
|
BPMC
34
DELISTED
Blueprint Medicines
BPMC
| $5.86M | 1.05% |
67,143
-111,786
| -62% | -$9.75M |
|
35
Syndax Pharmaceuticals
SNDX
$1.41B
| $5.84M | 1.05% |
441,587
-745,578
| -63% | -$9.86M |
|
36
Praxis Precision Medicines
PRAX
$958M
| $3.5M | 0.63% |
+45,536
| New | +$3.5M |
|
37
Cytokinetics
CYTK
$4.23B
| – | – |
-223,147
| Closed | -$11.8M |
|
|
38
Establishment Labs
ESTA
$1.2B
| – | – |
-357,003
| Closed | -$15.4M |
|
39
KalVista Pharmaceuticals
KALV
$678M
| – | – |
-355,000
| Closed | -$4.11M |
|
|
40
Krystal Biotech
KRYS
$4.27B
| – | – |
-67,942
| Closed | -$12.4M |
|
41
Rocket Pharmaceuticals
RCKT
$354M
| – | – |
-621,306
| Closed | -$11.5M |
|
|
42
Repligen
RGEN
$6.88B
| – | – |
-88,714
| Closed | -$13.2M |
|
43
Relay Therapeutics
RLAY
$619M
| – | – |
-1,226,354
| Closed | -$8.68M |
|
|
44
Transmedics
TMDX
$3.92B
| – | – |
-114,247
| Closed | -$17.9M |
|
|
45
Vertex Pharmaceuticals
VRTX
$100B
| – | – |
-35,222
| Closed | -$16.4M |
|